Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transplant Co-Morbidity Superpanel v0.8 | UGT1A1 | Bryony Thompson Marked gene: UGT1A1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplant Co-Morbidity Superpanel v0.8 | UGT1A1 | Bryony Thompson Gene: ugt1a1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplant Co-Morbidity Superpanel v0.8 | UGT1A1 | Bryony Thompson Classified gene: UGT1A1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplant Co-Morbidity Superpanel v0.8 | UGT1A1 | Bryony Thompson Gene: ugt1a1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transplant Co-Morbidity Superpanel v0.4 | UGT1A1 |
Claire Fryer-Smith gene: UGT1A1 was added gene: UGT1A1 was added to Transplant Co-Morbidity Superpanel. Sources: Expert list Mode of inheritance for gene: UGT1A1 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Phenotypes for gene: UGT1A1 were set to Hyperbilirubinemia, familial transient neonatal MIM# 237900; Crigler-Najjar syndrome, type I MIM#218800; Crigler-Najjar syndrome, type II MIM#606785 Review for gene: UGT1A1 was set to GREEN Added comment: Alleles in UGT1A1 are involved in guidelines for atazanavir and irinotecan. https://www.pharmgkb.org/gene/PA420/overview Sources: Expert list |